Therapeutic efficacy and safety of S-1-based combination therapy compare with S-1 monotherapy following gemcitabine failure in pancreatic cancer: a meta-analysis

S-1 monotherapy is widely used following gemcitabine failure in pancreatic cancer, especially in East Asia. We performed a meta-analysis to determine whether S-1-based combination therapy had better efficacy and safety compared with S-1 monotherapy. We searched Pubmed, Web of Science, ClinicalTrials...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Sinan, Zhang, Yuan, Zhou, Xiaohu, Zhou, Dongkai, Yang, Qifan, Ju, Bingjie, Zhao, Xinyi, Hu, Zhenhua, Xie, Haiyang, Zhou, Lin, Zheng, Shusen, Wang, Weilin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5105146/
https://www.ncbi.nlm.nih.gov/pubmed/27833144
http://dx.doi.org/10.1038/srep36944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5105146/
https://www.ncbi.nlm.nih.gov/pubmed/27833144
http://dx.doi.org/10.1038/srep36944

Ejemplares similares